相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The collagen receptor uPARAP/Endo180 in tissue degradation and cancer
Maria C. Melander et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
AGE-modified basement membrane cooperates with Endo180 to promote epithelial cell invasiveness and decrease prostate cancer survival
Mercedes Rodriguez-Teja et al.
JOURNAL OF PATHOLOGY (2015)
Survival Outcome and EMT Suppression Mediated by a Lectin Domain Interaction of Endo180 and CD147
Mercedes Rodriguez-Teja et al.
MOLECULAR CANCER RESEARCH (2015)
Does collagen trigger the recruitment of osteoblasts into vacated bone resorption lacunae during bone remodeling?
Mohamed Essameldin Abdelgawad et al.
BONE (2014)
Complex Determinants in Specific Members of the Mannose Receptor Family Govern Collagen Endocytosis
Henrik J. Juergensen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Bisphosphonates Inhibit Osteosarcoma-Mediated Osteolysis Via Attenuation of Tumor Expression of MCP-1 and RANKL
Tetsuro Ohba et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2014)
A New Role for Myosin II in Vesicle Fission
Juan A. Flores et al.
PLOS ONE (2014)
Acidic extracellular microenvironment and cancer
Yasumasa Kato et al.
CANCER CELL INTERNATIONAL (2013)
Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: A report from the Children's Oncology Group
Robert E. Goldsby et al.
EUROPEAN JOURNAL OF CANCER (2013)
Differential Actions of the Endocytic Collagen Receptor uPARAP/Endo180 and the Collagenase MMP-2 in Bone Homeostasis
Daniel H. Madsen et al.
PLOS ONE (2013)
New targets and approaches in osteosarcoma
Jonathan Gill et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Seed, soil and secreted hormones: Potential interactions of breast cancer cells with their endocrine/paracrine microenvironment and implications for treatment with bisphosphonates
C. Wilson et al.
CANCER TREATMENT REVIEWS (2012)
Serum Lactate Dehydrogenase Is Prognostic for Survival in Patients with Bone Metastases from Breast Cancer: A Retrospective Analysis in Bisphosphonate-Treated Patients
Janet E. Brown et al.
CLINICAL CANCER RESEARCH (2012)
TGFβ1-Endo180-dependent collagen deposition is dysregulated at the tumour-stromal interface in bone metastasis
Matthew P. Caley et al.
JOURNAL OF PATHOLOGY (2012)
Endocytic collagen degradation: a novel mechanism involved in protection against liver fibrosis
Daniel H. Madsen et al.
JOURNAL OF PATHOLOGY (2012)
Establishment and characterization of a sustained delayed-type hypersensitivity model with arthritic manifestations in C57BL/6J mice
Sara M. Atkinson et al.
ARTHRITIS RESEARCH & THERAPY (2012)
The Non-phagocytic Route of Collagen Uptake A DISTINCT DEGRADATION PATHWAY
Daniel H. Madsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
A Novel Functional Role of Collagen Glycosylation INTERACTION WITH THE ENDOCYTIC COLLAGEN RECEPTOR uPARAP/ENDO180
Henrik J. Jurgensen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Bone metastasis in prostate cancer: emerging therapeutic strategies (vol 8, pg 357, 2011)
Justin Sturge et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone
L. Endo-Munoz et al.
BRITISH JOURNAL OF CANCER (2010)
Intraperitoneal injection of thalidomide attenuates bone cancer pain and decreases spinal tumor necrosis factor-α expression in a mouse model
Xiaoping Gu et al.
MOLECULAR PAIN (2010)
Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models
Huiping Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression
Giolanta Kogianni et al.
EUROPEAN JOURNAL OF CANCER (2009)
The collagen receptor uPARAP/Endo180
Lars H. Engelholm et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Cancer-induced bone loss and associated pain-related behavior is reduced by risedronate but not its phosphonocarboxylate analog NE-10790
Andreas Hald et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis
Manav Korpal et al.
NATURE MEDICINE (2009)
Balancing Selection of a Frame-Shift Mutation in the MRC2 Gene Accounts for the Outbreak of the Crooked Tail Syndrome in Belgian Blue Cattle
Corinne Fasquelle et al.
PLOS GENETICS (2009)
Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model
Kasper Almholt et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Extracellular Collagenases and the Endocytic receptor, urokinase plasminogen activator receptor-associated Protein/Endo180, cooperate in fibroblast-mediated collagen degradation
Daniel H. Madsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Systemic administration of anti-urokinase plasminogen activator receptor monoclonal antibodies induces hepatic fibrin deposition in tissue-type plasminogen activator deficient mice
A. Joegi et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Complementary roles of intracellular and pericellular collagen degradation pathways in vivo
Rebecca A. Wagenaar-Miller et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Increased expression of the collagen internalization receptor uPARAP/Endo180 in the stroma of head and neck cancer
Jay Sulek et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2007)
Endosomes generate localized Rho-ROCK-MLC2 based contractile signals via Endo180 to promote adhesion disassembly
Justin Sturge et al.
JOURNAL OF CELL BIOLOGY (2006)
The influence of MMP-14, TIMP-2 and MMP-2 expression on breast cancer prognosis
Bernard Tetu et al.
BREAST CANCER RESEARCH (2006)
Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity:: A joint study by the Italian and Scandinavian Sarcoma Groups
S Ferrari et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Intracellular collagen degradation mediated by uPARAP/Endo 180 is a major pathway of extracellular matrix turnover during malignancy
AC Curino et al.
JOURNAL OF CELL BIOLOGY (2005)
The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling
N Behrendt
BIOLOGICAL CHEMISTRY (2004)
uPARAP/endo180 directs lysosomal delivery and degradation of collagen IV
L Kjoller et al.
EXPERIMENTAL CELL RESEARCH (2004)
Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone
XM Dai et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Identification and characterization of the endocytic transmembrane glycoprotein Endo180 as a novel collagen receptor
D Wienke et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix
KB Hotary et al.
CELL (2003)
A targeted deletion in the endocytic receptor gene Endo180 results in a defect in collagen uptake
L East et al.
EMBO REPORTS (2003)
uPARAP/Endo 180 is essential for cellular uptake of collagen and promotes fibroblast collagen adhesion
LH Engelholm et al.
JOURNAL OF CELL BIOLOGY (2003)
Metastasis to bone: Causes, consequences and therapeutic opportunities
GR Mundy
NATURE REVIEWS CANCER (2002)
Urokinase receptor-associated protein (uPARAP) is expressed in connection with malignant as well as benign lesions of the human breast and occurs in specific populations of stromal cells
BS Nielsen et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
LM Coussens et al.
SCIENCE (2002)
The bone lining cell: Its role in cleaning Howship's lacunae and initiating bone formation
V Everts et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
The urokinase plasminogen activator receptor-associated Protein/Endo180 is coexpressed with its interaction partners urokinase plasminogen activator receptor and matrix metalloprotease-13 during osteogenesis
LH Engelholm et al.
LABORATORY INVESTIGATION (2001)
A urokinase receptor-associated protein with specific collagen binding properties
N Behrendt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
